The team of researchers led by Simone Cenci, Director of the Genetics and Cell Biology Division, group leader of the Age Related Diseases lab at IRCCS Ospedale San Raffaele and Professor at Vita-Salute San Raffaele University, and by Doctor Matteo Bellone, group leader of the Cellular Immunology Lab at IRCCS Ospedale San Raffaele, has identified the mitochondrial protease ClpP as a novel potential target for the treatment of multiple myeloma (MM).
